Laboratory studies with classical renal carcinogens in the rat and mouse, as well as research investigation with some of the chemicals proving positive for the kidney in National Toxicology Program carcinogenicity bioassays, have demonstrated the existence of a range of diverse mechanisms underlying rodent kidney carcinogenesis. The classical carcinogens used as experimental models for studying renal tumor pathogenesis, such as the nitrosamines, are genotoxic and interact directly with DNA, forming DNA adducts with mutagenic potential. In contrast, potassium bromate and femc nitrilotriacetate (Fe-NTA), also effective renal carcinogens, appear to cause indirect damage to DNA mediated by oxidative stress. A number of nongenotoxic chemicals are associated with epigenetic renal tumor induction in rodents, and the activity of these tends to involve prolonged stimulation of cell proliferation throughout the duration of exposure. This mode of action reflects a sustained regenerative response, either due to dircct chemical toxicity to the tubule cells, as with chloroform, or to indirect cytotoxicity associated with lysosomal overload, as in a,,-globulin accumulation in male rats resulting from the administration of such chemicals as d-limonene and tetrachloroethylene. The histopathologic nature of hydroquinone renal carcinogenesis suggests that an additional epigenetic pathway to renal tubule tumor formation in rats may be through chemicalmediated exacerbation of, and interaction with, the age-related spontaneous renal disease, chronic progressive nephropathy. These various mechanistic pathways have implications for the nature of the induced cancer process with respect to tumor incidence, latency, malignancy, and sex predisposition.
INTRODUCTION
In the rodent species used in bioassays for testing the potential carcinogenic activity of chemicals, the renal tumor types derive from the epithelium, the connective tissue, or the embryonic primordia. Thus, the main tumor lineages in the rat kidney are represented by tumors developing from renal tubules (adenomas and carcinomas), transitional or squamous cell carcinomas deriving from renal pelvic urothelium, renal mesenchymal tumor and lipomatous tumors (lipoma and liposarcoma) originating in interstitial connective tissue, and tumors of embryonal primordia, nephroblastomas (34). In the mouse kidney, the vast majority of tumors encountered are of epithelial origin and tumors of connective tissue and embryonal primordia are exceedingly rare.
Mechanistic data on renal carcinogenesis in rodent kidney have been largely contributed from experimental studies using classical genotoxic carcinogens from established animal models of renal cancer induction. However, a significant stimulus for research into mechanisms has also come from the results generated by the National Cancer Institute/National Toxicology Program (NCI/ NTP) carcinogenicity bioassay program. In contrast to the classical experimental models, many of the chemicals testing positive for the kidney in the conventional rodent bioassay are nongenotoxic. Whereas the classical renal carcinogens have been associated with a range of tumor types including renal tubule tumors, carcinomas of the renal pelvis, renal mesenchymal tumor, and nephroblastoma, investigative studies emanating from positive results of the NCI/NTP bioassays have exclusively involved renal tubule tumors. As of July 1996, the NCI/ NTP carcinogenicity bioassay database contained 457 tested chemicals. Of these, 56 were associated with an increase in renal tumor incidence over controls, although in some cases the evidence was rated as equivocal (33).
Only 2 types of renal tumors have been induced in the NCI/NTP bioassays, the predominant form by far being the renal tubule tumor. Fifty-one of the positive chemicals were associated with increases in this tumor type in rats and/or mice, while 8 chemicals were associated with transitional cell tumors of the renal pelvis. As a consequence of the effort devoted to experimental investigation of renal carcinogenesis, either involving classical carcinogens or chemicals testing positive for the kidney in the carcinogenicity testing program, almost all of the mechanistic data relate to renal tubule tumor.
Based on the information currently available, the mechanisms underlying chemically induced rodent renal carcinogenesis fall into 4 categories. These are: 1) direct DNA reactivity, 2) indirect DNA reactivity mediated by oxidative stress, 3) sustained stimulation of tubule cell proliferation, and 4) interaction with spontaneous chronic progressive nephropathy. Kidney cancer induction through a mechanism of sustained stimulation of cell proliferation can be further subcategorized as being related to a regenerative response to either direct, or alternatively, indirect cytotoxicity. Each of these mechanistic pathways will be considered in turn in this review.
TUhlOR INDUCTION AS A RESULT OF DIRECT DNA

REACTIVITY
The classical renal carcinogens used for studying kidney carcinogenesis in established animal models are genotoxic chemicals in the sense that they, or their proximate metabolites, are electrophilic molecules that are capable of interacting directly with nucleophilic sites on cellular macromolecules, including DNA. Such chemicals are consistently genotoxic in a battery of short-term tests for mutagenicity or chromosomal aberrations, and a number have been identified as forming DNA adducts of various types in rodent tissues.
Examples of genotoxic renal carcinogens shown or presumed to interact directly with kidney DNA are listed in Table I , along with the tumor type induced. Nitrosamines and related compounds are well represented in this class, and some, such as dimethylnitrosamine (DMN) and cycasin, are versatile carcinogens, each being able to induce tumors of 2 different types, namely renal tubule and renal mesenchymal tumors (32). Mycotoxins also tend to target the rodent kidney. Ochratoxin A, a fungal metabolite produced by certain Aspergillus and Penicilliicni species, has proved to be the most potent renal carcinogen of the chemicals tested to date in the NCI/NTP bioassays (8). Another nitrosamine, bis-(2-oxopro-py1)nitrosamine (BOPN), has been used to induce transitional cell tumors of the rat renal pelvis (82) . while ethylnitrosourea (ENU) is associated with nephroblastomas when administered transplacentally to rats (3 1).
Excluding the nitrosoureas (e.g., ENU) and methyl-methane sulfonate, which are molecular species that interact directly with cellular macromolecules without metabolic activation, most genotoxic renal carcinogens require metabolic biotransformation into a proximate reactive species. Thus, DMN is metabolized in the proximal tubules of rats by the cytochrome P-450 monooxygenase, CYPIIEI in the presence of NADPH and oxygen (43, probably in the second segment (P2) of the proximal convoluted tubule (39). The metabolic pathway is believed to involve the sequential formation of such ephemeral compounds as methylhydroxymethylnitrosamine, monomethylnitrosamine, and methyldiazohydroxide, ultimately leading to the methyldiazonium cation, CH3NZ+, which is considered to be the putative reactive species acting as an S,l-like methylating agent (64). DMN is known to produce 2 major types of covalent adducts in rat kidney, N7-methylguanine and 06-methylguanine (16, 67) . Alkylation of the O6 site is a promutagenic lesion that correlates best with the organ specificity of DMN's carcinogenic action. Although rat kidney contains a protein that catalyzes the transfer of the methyl group from 06-methylguanine in DNA to a protein-bound cysteine residue (70), it appears that DMN at high doses inhibits this enzymatic repair process (69) . After administration of low (noncarcinogenic) and high (carcinogenic) doses of DMN, N7-methylguanine is rapidly removed by DNA repair mechanisms, as is the O6 adduct at the low (noncarcinogenic) doses. However, at the high doses that produce renal tumors, the O6 adduct is not efficiently repaired and, consequently, persists in the renal tissue (67) . Using an immunohistochemical procedure for cellular localization of 06-methylguanine in rat kidney, this modification to DNA and its persistence can be demonstrated in both renal cortical tubule cells and mesenchymal interstitial cells in the cortex (21, 22), the respective target cells from which DMN-induced renal tubule and mesenchymal tumors develop (32). The same promutagenic adduct, as well as overexpression of the associated repair enzyme alkylguanine alkyltransferase, have also been detected in monkey kidney DNA after oral administration of DMN (3). Ochratoxin A, a mycotoxin and food contaminant to which humans are exposed, is one chemical tested in the diet for carcinogenicity by the NTP that might act in the rat kidney via this mechanism. It is also a potent renal carcinogen in mice (50). Ochratoxin A circulates in a bound state to albumin and subsequently accumulates in the kidney where it binds preferentially to tubule cell organelles (76) . Early data on the genotoxicity of ochratoxin A have been contradictory, but more recent results from short-term tests clearly establish the mutagenicity of the biotransformed compound (42, 65). Ochratoxin A has been shown to produce DNA adducts in mouse kidney at a rate of 40 adducts per lo9 nucleotides (71) . Several DNA adducts, similar to those formed in mouse kidney, have also been detected in monkey kidney cells exposed to ochratoxin A in vifro (27) .
In general, the renal carcinogenic process initiated by genotoxic chemicals exhibits certain features that do not characterize the kidney tumors associated with nongenotoxic renal carcinogens. Genotoxic chemicals can be ef-106 HARD TOXICOLOGIC PATHOLOGY fective inducers of renal tumors in rats and mice following abbreviated dosing regimens. The tumor incidence is often very high, and the latency period relatively short with both sexes usually being susceptible. Renal tubule tumors induced by genotoxic carcinogens invariably occur against a conspicuous background of preneoplastic lesions in the form of foci of atypical tubule hyperplasia (13, 38) but are not linked with the presence of chronic progressive nephropathy (CPN). In addition, metastases to distant organs are sometimes observed with potent genotoxic carcinogens. By way of example, DMN, under certain conditions, can induce up to a 90% incidence of renal tubule or mesenchymal tumors in rats following a single intraperitoneal injection (29, 36) , whereas a 2-wk feeding regimen of Nethyl-N-hydroxyethylnitrosamine (EHEN) is sufficient for producing an 80% incidence of renal tubule tumors (43). A single intravenous injection of streptozotocin induces nearly a 100% incidence of renal tubule adenomas and carcinomas in mice (30). With DMN, some of the tumors metastasize, mainly to the lung, providing the animal survives long enough and the primary tumor reaches certain dimensions (29). In the 2-yr NTP bioassay with ochratoxin A administered in the diet, the renal tubule tumor incidence was the highest recorded for any of the chemicals testing positive in the NCI/NTP series, being 60% in the male rats with an unusually high metastasis rate of 37%. Female rats also developed renal tumors but at a lower incidence (8). In this study, renal tubule adenoma occurred as early as 9 mo after the commencement of oral gavage administration, which is most unusual in a conventional carcinogenicity bioassay. In the single dose-DMN model, adenomas have developed as rapidly as 3 mo postinjection (37).
TUhlOR INDUCTION LINKED TO INDIRECT DNA REACTIVITY
MEDIATED BY OXIDATIVE STRESS There is accumulating evidence that certain transition metals, for example the ferric and nickel ions, as well as potassium bromate, produce renal tubule tumors in rats or mice by indirectly causing DNA damage through the mediation of free radicals, in particular reactive oxygen species. More than 20 different types of DNA modifications are formed under the conditions of oxidative stress (28), but 8-hydroxy-2'-deoxyguanosine (8-OHdG) is the most abundant and therefore one of the most popular markers for DNA damage rendered by such reactive species as singlet oxygen and the hydroxyl radical (24). The 8-OHdG adduct can cause misreading of the DNA sequence during replication associated with G to T base transversions (77) and is therefore likely to be involved in mutagenesis and carcinogenesis. Furthermore the aldehydic product 4-hydroxy-2-nonenal is regarded as a reliable index of free radical-induced toxicity relevant to lipid peroxidation (6).
The evidence linking both the femc ion and potassium bromate to oxidative DNA damage is substantial. Iron overload in rodents can be achieved by intraperitoneal administration of the ferric ion chelated to nitrilotriacetate as a complex (Fe-NTA). As a subacute effect, Fe-NTA causes proximal tubule cell necrosis in both mice and rats (17, 61) . It has been proposed that Fe-NTA is filtered at the glomerulus and is then exposed to high cysteine levels at the proximal tubule brush border, with subsequent reduction of the ferric complex (Fe III-NTA) by cysteine to the ferrous complex (Fe II-NTA). The auto-oxidation of the ferrous ion generates the superoxide anion radical, causing lipid peroxidation (72) . Accordingly, formation of 4-hydroxy-2-nonena1, the marker of lipid peroxidation, as well as 4-hydroxy-2-nonenal-modified proteins, have been observed in rat kidney exposed to Fe-NTA. The modified proteins were associated in particular with proximal tubule cells undergoing necrosis in response to the renal carcinogen (92) . On the other hand, significantly increased levels of 8-OHdG have been detected in treated rat kidney, indicative of oxidative DNA damage (90, 93) . In keeping, this is accompanied by a significant increase in repair activity of 8-hydroxyguanine (98) . DNA-base modifications typical of hydroxyl radical oxidative damage have been described in renal chromatin from Fe-NTA-treated rats (86) . Fe-NTA also induces oxidative production of DNA single-and double-strand breaks in the presence of reducing agents in vitro (88), as well as formation of DNA-protein cross-links involving thymine and tyrosine in rat renal chromatin (87) . Increased nuclear 8-OHdG activity was localized to surviving proximal tubule cells adjacent to those undergoing necrosis (90) . A further piece of evidence linking Fe-NTA with oxidative damage is the demonstration of a protective effect against renal injury by certain antioxidants, for example probucol (72) and aG-rutin (78), presumably mediated by the scavenging of reactive oxygen species. Like the ferric ion, nickel I1 treatment also causes oxidative DNA damage in rat kidney (53).
Similar evidence exists for potassium bromate, an oxidizing food additive that has been used widely throughout the world for treatment of wheat flour in the breadmaking process. Several studies have shown that potassium bromate increases the levels of 8-OHdG in rat kidney DNA at doses carcinogenic for the target organ (52, 74, 94) . The levels of 8-OHdG persisted in rat kidney, compared to liver, at relatively high levels, suggesting a slow rate of repair of the DNA oxidative damage produced by this compound (12). In addition, there are in vitro findings with potassium bromate that support the involvement of lipid peroxidation in producing oxidized DNA damage directly to proximal tubule cells (75) .
Chemicals acting through this mechanism tend to be reactive in some short-term tests for genotoxicity. Thus Fe-NTA (89) and potassium bromate (48) have been shown to have some mutagenic properties. Such compounds also have the capability of producing high incidences of renal tumors, with more than one species (e.g., rats and mice) and both sexes sometimes being susceptible to renal tubule tumor induction by appropriate doses and routes of administration. Thus, potassium bromate has induced up to 90% renal tumor incidence in male rats and up to 70% in female rats (55). Fe-NTA has produced renal tubule tumors in up to an 80% frequency in both male rats and mice (17, 61). Tumor induction by this mechanism can sometimes be detected within a 12-mo at SAGE PUBLICATIONS on December 9, 2012 tpx.sagepub.com Downloaded from Vol. 26, No. 1, 1998 RENAL CARCINOGENESIS MECHANISMS 107 period (17, 55, 91) and metastasis has been recorded (61, 91).
TUhlOR INDUCTION ASSOCIATED WITH SUSTAINED REGENERATIVE CELL PROLIFERATION Many chemical compounds inducing renal tumors in rodents are nongenotoxic; that is, they are not' directly or indirectly DNA reactive and appear to induce kidney tumors via epigenetic pathways. One of these pathways involves sustained stimulation of cell proliferation as a regenerative response to the chemical's pathophysiologic effects. In the rodent kidney this category can be subdivided further into 2 separate pathways: one involving a regenerative response to direct cytotoxicity elicited by the chemical, and a second involving a regenerative response to indirect cytotoxicity . caused by cellular lysosomal overload. Chemicals acting via these pathways tend to induce low incidences of renal tubule tumors, with a long latency, the tumors most often being observed at the end of the 2-yr testing period, and usually involving only the male animal. Furthermore, tumor metastasis in these cases is rare.
The precise molecular mechanism whereby continual cell turnover leads into neoplastic cellular change has not been defined. Certainly, where there is increased cell proliferation, it is implied that an increased number of cells will be in S-phase of the cell cycle, and this is the most vulnerable point for DNA perturbation. Consequently, an increase in the spontaneous error rate in DNA replication may be involved, but additionally, the time available for repair of DNA damage would be decreased, resulting in a greater opportunity for the fixation of mutational events. Another possibility is that prolonged increase in cell proliferation might facilitate the clonal expansion of already initiated cells. Alternatively, it is possible that nonmutagenic DNA modifications may be facilitated, resulting in changes of gene expression relevant to carcinogenesis; for example, modifications involving the genes responsible for controlling check-points in the cell cycle.
Regenerative Response to Direct Cytotoxicity
An example of a rodent renal carcinogen in this category is chloroform. The weight of evidence from mutagenicity and related short-term tests indicates that neither chloroform or its metabolites are able to interact directly with DNA or possess genotoxic activity (47). Nevertheless, chloroform has induced low to moderate incidences (up to 26%) of renal tubule tumors in the males only of Osborne-Mendel rats (49), and BDF, (T Matsushima, personal communication) and ICI (73) mice. In the mouse, there is strong evidence that chloroform is localized in proximal convoluted tubule cells (46), where it is metabolized via the P-450-dependent oxidative pathway specifically involving CYPiIE1 (9). Covalent binding of chloroform to renal proteins and microsomes precedes, and is highly correlated with, the epithelial cell necrosis that ensues in the same segment of the renal tubule. These various intermediate end-points representing cellular accumulation, microsomal binding, CYPIIEl activity, and renal metabolism of chloroform all correlate strongly with the gender and genetic differences in susceptibility of mice to chloroform's renal cytotoxic action (1, 44, 56, 81, 85) . In turn, there is a.very tight correlation in mice between the compound-induced nephrotoxicity, sustained regenerative tubule cell proliferation, and occurrence of renal tubule tumors (10).
In rats, the link between CYPIIEl metabolism and renal cytotoxicity is not as clear-cut as with the mouse, and, because of health status concerns, the Osborne-Mendel rat (the only rat strain testing positive for renal tumors with chloroform to date) has received little attention in quantitatively useful intermediate end point studies. Whereas it has been established that chloroform induces nephrotoxicity accompanied by sustained regenerative tubule cell proliferation in the Fischer 344 rat (57, 58), this strain tested negatively for renal tumors in a 2-yr bioassay with chloroform (T Matsushima, personal communication). Consequently, the author of this review re-evaluated the histology slides of kidney from the positive Environmental Protection Agency (EPA) carcinogenicity study of chloroform administered in drinking water (49) for evidence of renal tubule injury (35). This examination was able to demonstrate the presence of a mild to moderate level of cellular change indicative of sustained tubule damage accompanied by regeneration in all rats of the high-dose (160 mg/kg/day) group of males, which developed a 14% incidence of renal tubule tumors. The results of the re-evaluation of the rat study strongly supported the concept that chloroform-mediated induction of renal tubule tumors is highly correlated with chronic, chemically induced renal tubule injury and the prolonged stimulus for regenerative cell proliferation.
Regeiterrrtive Response to Indirect Cytotoxicity
The male rat kidney is unique in being susceptible to tumor induction dependent on chemical interference with a specific physiologic function at the cellular level. Conventional male rats, but not female rats, are physiologically proteinuric because of high urinary levels of a lowmolecular-weight protein, alpha-2u-globulin (or,,-g), belonging to the lipocalin superfamily of proteins (23). This protein (molecular weight 18,000-20,0OO daltons) is synthesized predominantly in the liver of the male rat, where the mRNA for a,,-grepresents about 1% of total hepatic mRNA (80). As with other circulating low-molecularweight proteins, a2,-g is passed freely through the glomerular filtration barrier into the tubules, with 40% being excreted in the urine and 60% endocytosed by the cells of the second segment (P2) of the proximal tubule, where it undergoes hydrolytic catabolism within cellular phagolysosomes (60, 66) .
A number of diverse chemical substances have been recorded as producing a special form of nephropathy in male rats but not in female rats or mice of either sex. The most prominent histological feature of the syndrome is the excessive accumulation of eosinophilic, hyaline droplets in epithelial cells of the P2 segment of proximal tubule; hence, the term "hyaline droplet nephropathy" is sometimes used to denote this condition (40, 83) . Several of these chemicals have produced low incidences, up to 28%, of renal tubule tumors in male rats, when tested in carcinogenicity bioassays. Examples of these male rat re-108 HARD TOXICOLOGIC PATHOLOGY nal carcinogens (see Table 11 ) include the food constituent d-limonene, tetrachloroethylene, a solvent used in the dry-cleaning industry, the insect repellent 1,4-dichlorobenzene, dimethyl methylphosphonate, a plasticizer, and fuels such as unleaded gasoline and certain jet propellants (40). The initiating step in the mechanism underlying the production of hyaline droplet nephropathy is the loose, noncovalent binding of the inducing chemical to the azug molecule (63). This molecule is an 8-stranded antiparallel P-barrel enclosing a hydrophobic, cup-shaped pocket representing an internal ligand binding site (23). It is believed that the chemical attaches within this internal binding site where its presence has been shown to interfere with intrarenal degradation of azu-g by lysosomal hydrolases, prolonging an already very long half-life for a low-molecular-weight protein of 5-8 hr by at least 30% (60). The resulting accumulation of azu-g in P2 tubule cells leads to lysosomal overload, visible microscopically as cytoplasmic accumulation of hyaline droplets. Lyso-soma1 overload of tubule cells results in single cell degeneration and detachment into the tubule lumen. In turn, there is a compensatory cell proliferation that continues as long as exposure to the chemical (79) . Thus, the tubule cell cytotoxicity is a consequence of interference with a physiologic process and not due to a direct injurious action of the inciting chemical on cellular constituents. This is further supported by negative iiz vitro studies where such chemicals as 2,4,4-trirnethyl-2-pentanol were exposed to male rat renal tubule cells in culture without causing cytotoxicity (96) . A number of studies substantiate a tight correlation between the requirement for high levels of azu-g and the expression of hyaline droplet accumulation. These include the age and gender differences in susceptibility to chemical induction of hyaline drophlet nephropathy (40), but the most compelling evidence comes from studies with a genetically defective rat and a transgenic mouse. The male NCI Black Reiter (NBR) rat lacks mRNA for aZu-g in the liver (1 1) and consequently does not develop the distinctive nephropathy when challenged with such chemicals as d-limonene or 1,4-dichlorobenzene (14). On the other hand, in a mouse strain modified transgenically to express azU-g, d-limonene does elicit hyaline droplet nephropathy, contrary to the situation in conventional mice (59).
The link between tubule cell proliferation associated with hyaline droplet nephropathy and renal tumors is supported mainly by 2 studies. Short et a1 (79) have dem-onstrated with unleaded gasoline that an increased labeling index indicative of DNA synthesis in cortical tubule cells is sustained chronically throughout and beyond the period of chemical exposure. The same laboratory has also shown in an initiatiodpromotion model with EHEN as the initiating agent, that, in contrast to Fischer 344 rats, NBR rats do not respond to d-limonene with an increased tubule cell proliferative rate and do not develop an increase in renal tumors beyond the background of the EHEN control groups (15). This well-studied a,,-g/male rat paradigm provides a striking example of an epigenetic mechanism of renal tumor induction that has no relevance to humans.
TUhlOR INDUCTION REFLECTING INTERACTION OF
CHEhlICALS WITH SPONTANEOUS CPN CPN is a spontaneous, age-related renal disease affecting rats of the various strains used in carcinogenicity bioassays. Male rats are more severely affected than females (18) and a similar disease can be observed in laboratory mice (97) .
In the earlier stages, CPN is characterized at the light microscope level as occasional, small, and discrete foci of basophilic tubules with thickened basement membranes located in the cortex. This change is associated with an eosinophilic hyaline cast in the same tubule segment downstream in the medulla. With progression, more tubules become affected and foci merge into areas of tubule alteration, accompanied by frank glomerular pathology and some interstitial infiltration by mononuclear inflammatory cells. Affected tubules display a. range of changes including degeneration, atrophy, and regeneration in the form of simple tubule hyperplasia (5, 26, 34) . Studies measuring DNA synthesis have confirmed that CPN-involved tubules have a high proliferative activity (54, 79, 84) as depicted in Fig. 1 . In very advanced stages of the disease, virtually all of the renal parenchyma is involved in pathoIogic alteration, and at this point an occasional focus of atypical tubule hyperplasia (accompanied by thickened basement membrane) may be present (7, 25, 34) . Because of its substantial regenerative component, persisting through all stages of the disease process, the possibility that CPN might be a factor in renal tumor development has been raised on occasion (2, 62). In this respect, there has been suggestive evidence from an in-depth study of age-associated lesions of Sprague-Dawley rats from 2 different stocks allowed to live into senescence (4). The stock having significantly more severe CPN also had a higher frequency of spontaneous renal adenomas over comparable age groups and life span.
Hydroquinone has been proposed as an example of a chemical that interacts with this spontaneous renal disease to indirectly produce a minimal renal tubule tumor response (41). Hydroquinone is a synthetic reagent with a wide range of commercial applications involving human exposure. However, such a mechanism in rodents would have little relevance for humans because there is no histopathologically analogous age-related renal disease in humans.
Hydroquinone is negative in tests for genotoxicity, ex- cept for cytogenetic changes in bone-marrow cells ( 9 3 , and is negative for DNA adduct formation in rat kidney (19). Nevertheless, hydroquinone has been linked to renal tumor induction in an NTP carcinogenicity bioassay with Fischer 344 rats (51, 68). The tumors, renal tubule adenomas, occurred at very low incidence, and none were sufficiently large as to be observable on gross examination of the kidney. Hydroquinone has also been shown to have an early cytotoxic effect on renal tubule epithelium in rats that is not sustained and to exert a stimulatory effect on renal tubule cell proliferation (20) .
Upon independent re-evaluation of the kidney sections from the NTP study, a low incidence of foci of atypical tubule hyperplasia and small renal tubule adenomas in the low-(25 mg/kg/day) and high-(50 mg/kg/day) dose male groups were confirmed (Table III) , as well as a substantial exacerbation of CPN at the high dose (41). In each case, these preneoplastic or neoplastic tubule lesions occurred in rats with very advanced CPN and in areas of parenchyma affected by the disease process. This association between the renal proliferative foci and CPN was statistically significant. In addition, there was a dose-related increase in histological profiles believed to represent new, small tubule regeneration (STR) within areas of advanced CPN, as well as an apparent expansion of these into unusual complex tubule profiles in end-stage CPN- affected kidneys of the high-dose male group (Table 111 ). In particular, this latter observation suggests that hydroquinone was exerting a further proliferative stimulus on the already proliferative environment of CPN.
In this particular example, it is proposed that hydroquinone is interacting with CPN at two levels; first to exacerbate the spontaneous disease process, and second to provide an additional proliferative stimulus that drives simple tubule hyperplasia into foci of atypical tubule hyperplasia and/or the latter on to adenomas (41). Many chemicals with renal effects also enhance the onset and seventy of CPN, and it is conceivable that other examples of renal carcinogens operating via this interaction may exist. It would be expected that renal tumor induction mediated through this pathway would be a minimal response with respect to tumor incidence and tumor size or grade, probably occumng in male rats only. In the hydroquinone example, the tumor incidence was only 14% in the high-dose males, and almost half of the renal tumors encountered at or near the termination of the 2-yr study were borderline between atypical hyperplasia and adenomas. REFER E N c E s 1. Ahmadizadeh M, Echt R, Kuo CH, and Hook JB (1984) . Sex and strain differences in mouse kidney; Bowman's capsule morphology and susceptibility to chloroform. Toxicol. Lerr. 20: 161-172. 2. Alden CL and Frith CH (1991 
12.
13.
14.
15.
16.
17.
18.
19.
20.
21.
22.
23.
24.
25.
26.
27.
28.
29.
T O X~C O~. 16: 749-762.
nomdcarcinoma induction using dimethylnitrosamine in Crl: (W)BR rats. Cnrciriogeriesis 5: 1017-1050. 30. Hard GC (1985) . Identification of a high-frequency model for renal carcinoma by the induction of renal tumors in the mouse with a single dose of streptozotocin. Cancer Res. 45: 703-708. 31. Hard GC (1985) . Differential renal tumor response to N-ethylnitrosourea and dimethylnitrosamine in the Nb rat; basis for a new rodent model of nephroblastoma. Carcinogenesis 6: 155 1-1558.  32. Hard GC (1990) . Tumours of the kidney, renal pelvis and ureter.
In KT Kitchin (ed) . Marcel Dekker, New York (in press). 34. Hard GC, Alden CL, Stula EF, and Trump BF (1995) . Proliferative lesions of the kidney in rats. In: Guides for Toxicologic Pathology, STP/ARP/AFIP, Washington, DC, pp. 1-19. 35. Hard GC and Boorman GA (1997) . Re-evaluation of the chloroform 2-year carcinogenicity bioassays supports sustained renal tubule injury as a mode of action underlying the renal tumor response. Toxicol. Pafhol. (in preparation). 36. Hard GC and Butler WH (1970) . Cellular analysis of renal neoplasia: Induction of renal tumors in dietary-conditioned rats by dimethylnitrosamine, with a reappraisal of morphological characteristics. Cancer Res. 30: 2796-2805. 37. Hard GC and Butler WH (1971 World Health Organization, Geneva
